Thamotharampillai Dileepan

Thamotharampillai Dileepan

Auto-generated profile, based on publicly available information

Thamotharampillai Dileepan

Department of Microbiology and Immunology, University of Minnesota Medical School, Minneapolis, MN, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2009 in Nature Immunology
Verified
Journal Article
Open access
PDF file
MPMarion Pepper
Marion Pepper
JLJonathan L Linehan
Jonathan L Linehan
APAntonio J Pagán
Antonio J Pagán
TZTraci Zell
Traci Zell
TDThamotharampillai Dileepan
Thamotharampillai Dileepan
MJMarc K Jenkins
Marc K Jenkins
Naive CD4+ T cells can differentiate into distinct polarized effector cells, but detailed characterization of physiologic CD4 memory is lacking. Jenkins and colleagues show that TH1 and TH17 memory cells differ in longevity and arise via different infection routes. We used a sensitive method based on tetramers of peptide and major histocompatibility complex II (pMHCII) to determine whether CD4+ memory T cells resemble the T helper type 1 (TH1) and interleukin 17 (IL-17)-producing T helper (TH17) subsets described in vitro. Intravenous or intranasal infection with Listeria monocytogenes induced pMHCII-specific CD4+ naive T cells to proliferate and produce effector cells, about 10% of which resembled TH1 or TH17 cells, respectively. TH1 cells were also present among the memory cells that survived 3 months after infection, whereas TH17 cells disappeared. The short lifespan of TH17 cells was associated with small amounts of the antiapoptotic protein Bcl-2, the IL-15 receptor and the receptor CD27, and little homeostatic proliferation. These results suggest that TH1 cells induced by intravenous infection are more efficient at entering the memory pool than are TH17 cells induced by intranasal infection.

4 January 2016 in Nature Immunology
Verified
Journal Article
Open access
PDF file
DMDeepali Malhotra
Deepali Malhotra
JLJonathan L Linehan
Jonathan L Linehan
TDThamotharampillai Dileepan
Thamotharampillai Dileepan
YLYou Jeong Lee
You Jeong Lee
WPWhitney E Purtha
Whitney E Purtha
MJMarc K Jenkins
Marc K Jenkins
CD4+ T cell tolerance can be enforced by various mechanisms. Jenkins and colleagues use mice with entirely intact polyclonal T cell repertoires to comprehensively define the mechanisms of self-tolerance. Studies of repertoires of mouse monoclonal CD4+ T cells have revealed several mechanisms of self-tolerance; however, which mechanisms operate in normal repertoires is unclear. Here we studied polyclonal CD4+ T cells specific for green fluorescent protein expressed in various organs, which allowed us to determine the effects of specific expression patterns on the same epitope-specific T cells. Peptides presented uniformly by thymic antigen-presenting cells were tolerated by clonal deletion, whereas peptides excluded from the thymus were ignored. Peptides with limited thymic expression induced partial clonal deletion and impaired effector T cell potential but enhanced regulatory T cell potential. These mechanisms were also active for T cell populations specific for endogenously expressed self antigens. Thus, the immunotolerance of polyclonal CD4+ T cells was maintained by distinct mechanisms, according to self-peptide expression patterns.

11 September 2018 in Circulation
Verified
Journal Article
Closed access
PDF file
TKTakayuki Kimura
Takayuki Kimura
KKKouji Kobiyama
Kouji Kobiyama
HWHolger Winkels
Holger Winkels
KTKevin Tse
Kevin Tse
JMJacqueline Miller
Jacqueline Miller
KLKlaus Ley
Klaus Ley
Background: CD4 + T cells play an important role in atherosclerosis, but their antigen specificity is poorly understood. Immunization with apolipoprotein B (ApoB, core protein of low density lipoprotein) is known to be atheroprotective in animal models. Here, we report on a human APOB peptide, p18, that is sequence-identical in mouse ApoB and binds to both mouse and human major histocompatibility complex class II molecules. Methods: We constructed p18 tetramers to detect human and mouse APOB-specific T cells and assayed their phenotype by flow cytometry including CD4 lineage transcription factors, intracellular cytokines, and T cell receptor activation. Apolipoprotein E–deficient ( Apoe −/− ) mice were vaccinated with p18 peptide or adjuvants alone, and atherosclerotic burden in the aorta was determined. Results: In human peripheral blood mononuclear cells from donors without cardiovascular disease, p18 specific CD4 + T cells detected by a new human leukocyte antigen-antigen D related-p18 tetramers were mostly Foxp3 + regulatory T cells (Tregs). Donors with subclinical cardiovascular disease as detected by carotid artery ultrasound had Tregs coexpressing retinoic acid-related orphan receptor gamma t or T-bet, which were both almost absent in donors without cardiovascular disease. In Apoe −/− mice, immunization with p18 induced Tregs and reduced atherosclerotic lesions. After peptide restimulation, responding CD4 + T cells identified by Nur77-GFP (green fluorescent protein) were highly enriched in Tregs. A new mouse I-A b -p18 tetramer identified the expansion of p18-specific CD4 + T cells on vaccination, which were enriched for interleukin-10–producing Tregs. Conclusions: These findings show that APOB p18–specific CD4 + T cells are mainly Tregs in healthy donors, but coexpress other CD4 lineage transcription factors in donors with subclinical cardiovascular disease. This study identifies ApoB peptide 18 as the first Treg epitope in human and mouse atherosclerosis.

1 January 2015 in Immunity
Verified
Journal Article
Closed access
RNRyan W. Nelson
Ryan W. Nelson
DBDaniel Beisang
Daniel Beisang
NTNoah J. Tubo
Noah J. Tubo
TDThamotharampillai Dileepan
Thamotharampillai Dileepan
DWDarin L. Wiesner
Darin L. Wiesner
MJMarc K. Jenkins
Marc K. Jenkins

14 December 2015 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
TDThamotharampillai Dileepan
Thamotharampillai Dileepan
ESErica D. Smith
Erica D. Smith
DKDaniel Knowland
Daniel Knowland
MHMartin Hsu
Martin Hsu
MPMaryann Platt
Maryann Platt
PCP. Patrick Cleary
P. Patrick Cleary
Group A streptococcal (GAS) infection induces the production of Abs that cross-react with host neuronal proteins, and these anti-GAS mimetic Abs are associated with autoimmune diseases of the CNS. However, the mechanisms that allow these Abs to cross the blood-brain barrier (BBB) and induce neuropathology remain unresolved. We have previously shown that GAS infection in mouse models induces a robust Th17 response in nasal-associated lymphoid tissue (NALT). Here, we identified GAS-specific Th17 cells in tonsils of humans naturally exposed to GAS, prompting us to explore whether GAS-specific CD4+ T cells home to mouse brains following i.n. infection. Intranasal challenge of repeatedly GAS-inoculated mice promoted migration of GAS-specific Th17 cells from NALT into the brain, BBB breakdown, serum IgG deposition, microglial activation, and loss of excitatory synaptic proteins under conditions in which no viable bacteria were detected in CNS tissue. CD4+ T cells were predominantly located in the olfactory bulb (OB) and in other brain regions that receive direct input from the OB. Together, these findings provide insight into the immunopathology of neuropsychiatric complications that are associated with GAS infections and suggest that crosstalk between the CNS and cellular immunity may be a general mechanism by which infectious agents exacerbate symptoms associated with other CNS autoimmune disorders.

22 September 2011 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
TDThamotharampillai Dileepan
Thamotharampillai Dileepan
JLJonathan L Linehan
Jonathan L Linehan
JMJames J Moon
James J Moon
MPMarion Pepper
Marion Pepper
MJMarc K Jenkins
Marc K Jenkins
PCPatrick P Cleary
Patrick P Cleary
Group A streptococcus (GAS, Streptococcus pyogenes) is the cause of a variety of clinical conditions, ranging from pharyngitis to autoimmune disease. Peptide-major histocompatibility complex class II (pMHCII) tetramers have recently emerged as a highly sensitive means to quantify pMHCII-specific CD4+ helper T cells and evaluate their contribution to both protective immunity and autoimmune complications induced by specific bacterial pathogens. In lieu of identifying an immunodominant peptide expressed by GAS, a surrogate peptide (2W) was fused to the highly expressed M1 protein on the surface of GAS to allow in-depth analysis of the CD4+ helper T cell response in C57BL/6 mice that express the I-Ab MHCII molecule. Following intranasal inoculation with GAS-2W, antigen-experienced 2W:I-Ab-specific CD4+ T cells were identified in the nasal-associated lymphoid tissue (NALT) that produced IL-17A or IL-17A and IFN-γ if infection was recurrent. The dominant Th17 response was also dependent on the intranasal route of inoculation; intravenous or subcutaneous inoculations produced primarily IFN-γ+ 2W:I-Ab+ CD4+ T cells. The acquisition of IL-17A production by 2W:I-Ab-specific T cells and the capacity of mice to survive infection depended on the innate cytokine IL-6. IL-6-deficient mice that survived infection became long-term carriers despite the presence of abundant IFN-γ-producing 2W:I-Ab-specific CD4+ T cells. Our results suggest that an imbalance between IL-17- and IFN-γ-producing CD4+ T cells could contribute to GAS carriage in humans. Group A streptococcus (GAS) causes many different conditions, ranging from strep throat, flesh eating disease to post infectious complications involving the heart. Here, we used a novel technique to study the CD4+ T cell immune response against GAS infection in a mouse model. We first generated a recombinant GAS strain that expresses a specific epitope (2W) - M protein fusion and used this to intranasally inoculate mice. Peptide specific CD4+ T cells were concentrated and analyzed using 2W-MHC-II tetramers. This technology allowed us to probe the antigen specific CD4+ T cell response to new depths and certainty. Infection induced a robust 2W-specific Th17 cell response, which was dependent on the route of infection, IL-6, and was independent of superantigens. IL-6-/- mice were exquisitely susceptible to intranasal infection. However, those that survived became immune carriers, unable to clear streptococci from NALT. Further, multiple infections generated an IL-17+ IFN-γ+ double positive population of CD4+ T cells that are known to be associated with autoimmune disease in humans and directly responsible for autoimmune pathology in rodent models. Our results provide a new direction for understanding two important consequences of streptococcal pharyngitis, the very common immune carrier state, and the rarer state involving autoimmune complications.